| ORIGINAL ARTICLE |
|
| Year : 2015 | Volume
: 14
| Issue : 3 | Page : 148-154 |
|
|
Management of salivary gland tumors in a Nigerian tertiary institution
Benjamin Fomete1, ET Adebayo2, CN Ononiwu1
1 Maxillofacial Unit, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
2 Army Dental Centre, Bonny Camp, Ikoyi, Lagos, Department of Maxillofacial Surgery, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
Correspondence Address:
Benjamin Fomete
Maxillofacial Unit, Ahmadu Bello University Teaching Hospital, Zaria
Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1596-3519.152071
|
|
|
Background: The salivary glands consist of three major paired glands (the parotid, submandibular and sublingual) as well as numerous minor salivary glands, situated mostly in the oral cavity but also found in the pharynx, larynx, trachea, and sinuses. Tumours of salivary glands show a wide variety of pathologic types varying from benign to malignant. More salivary gland tumours are benign than malignant.
Patients and Methods: Data for this study were obtained from retrospective survey of case notes of all patients with Salivary gland tumours seen at the Maxillofacial Unit, Ahmadu Bello University Teaching Hospital, Shika, Zaria between January 2003 and August 2013.
Results: There were 135 patients 73 (54.1%) females and 62 (45.9%) males within the age range of 2.5 to 80 years (41.85 years). Thirty nine (28.9%) were benign while 96 (71.1%) were malignant. Major salivary glands were involved in 60.7% of tumours; the rest 39.3% involved minor salivary glands. Pleomorphic adenoma (86.7%) formed the bulk of benign tumours while adenoid cystic carcinoma (47.5%) was the predominant malignant tumour of salivary glands. Of 135 patients (n=,57.1% had surgery in our institution and were followed up. Those with malignancy also benefited from radiotherapy, chemotherapy or palliative oncology treatment.
Conclusion: Management of salivary glands tumours in our environment is a challenge due to late presentation and the size of the tumour. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
